CMS certification 310076
Cooperman Barnabas Medical Center
94 Old Short Hills Road, Livingston, NJ 07039
Cooperman Barnabas Medical Center has a CMS overall rating of 3 out of 5 stars. 71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 5. Emergency patients spend a median of 2 h 9 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 2,189 completed surveys, 16% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NJ | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 424 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 9 min | 3 h 6 min | 2 h 42 min |
| Left before being seen Lower is better · 101,415 patients | 0% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 139 patients | 74% | 73% | 65% |
How Cooperman Barnabas Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Cooperman Barnabas Medical CenterThis hospital | 3/5 | 71% | 2 h 9 min | 3 better 5 worse |
| Hackensack Meridian Mountainside MedicalSame county · Montclair | 4/5 | 62% | 3 h 49 min | 1 better 1 worse |
| Carewell Health Medical CenterSame county · East Orange | 1/5 | 42% | 2 h 56 min | 1 better 2 worse |
| VA New Jersey Health Care SystemSame county · East Orange | 2/5 | 66% | — | 1 better 2 worse |
| Saint Michael's Medical CenterSame county · Newark | 4/5 | 71% | 2 h 49 min | 2 better 1 worse |
| The University HospitalSame county · Newark | 1/5 | 56% | 5 h 7 min | 3 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,603 cases | Too few cases | 3.3% | 3.9% |
| Heart attack 166 cases | Too few cases | 10.6% | 11.9% |
| Heart failure 623 cases | Too few cases | 10% | 11.1% |
| Pneumonia 878 cases | Too few cases | 16.7% | 15.2% |
| Stroke 470 cases | Too few cases | 9.1% | 11.9% |
| COPD 131 cases | Too few cases | 8.9% | 8.6% |
| Heart bypass surgery (CABG) 140 cases | Too few cases | 2.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.9 likely 0.65 – 1.14 | 1 |
| After hip or knee replacement 68 cases | Too few cases | 3.4% | 4.1% |
| Deaths after a serious but treatable surgical complication 165 cases | Worse | 227.59 per 1,000 likely 184.41 per 1,000 – 270.78 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 10,444 cases | No different | 0.38 per 1,000 likely 0 per 1,000 – 0.88 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 12,045 cases | No different | 0.15 per 1,000 likely 0 per 1,000 – 0.32 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 12,482 cases | No different | 0.33 per 1,000 likely 0.15 per 1,000 – 0.5 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,225 cases | No different | 2.91 per 1,000 likely 1.8 per 1,000 – 4.03 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,230 cases | No different | 1.11 per 1,000 likely 0 per 1,000 – 2.52 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,358 cases | No different | 6.66 per 1,000 likely 1.62 per 1,000 – 11.7 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,321 cases | Worse | 6.12 per 1,000 likely 4.4 per 1,000 – 7.85 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,350 cases | No different | 3.57 per 1,000 likely 0.5 per 1,000 – 6.65 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,081 cases | No different | 2.18 per 1,000 likely 0.83 per 1,000 – 3.53 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,913 cases | No different | 1.02 per 1,000 likely 0.23 per 1,000 – 1.82 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.19 likely 0.06 – 0.45 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.27 likely 0.12 – 0.53 | 1 |
| Surgical site infections after colon surgery | No different | 0.79 likely 0.35 – 1.56 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.63 likely 0.66 – 3.39 | 1 |
| MRSA bloodstream infections | No different | 1.49 likely 0.9 – 2.34 | 1 |
| C. diff intestinal infections | Better | 0.4 likely 0.28 – 0.56 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 254 cases | Too few cases | 14.9% | 14.4% |
| Readmitted after heart failure 1,112 cases | Too few cases | 20.7% | 21.3% |
| Readmitted after pneumonia 1,170 cases | Too few cases | 18.5% | 17.3% |
| Readmitted after COPD 206 cases | Too few cases | 22.3% | 20% |
| Readmitted after heart bypass surgery 150 cases | Too few cases | 10.5% | 11% |
| Readmitted after hip or knee replacement 68 cases | Too few cases | 6.4% | 5.8% |
| Days back in hospital after a heart attack 185 cases | Too few cases | 16.6 days per 100 | — |
| Days back in hospital after heart failure 710 cases | Too few cases | 21.3 days per 100 | — |
| Days back in hospital after pneumonia 840 cases | Too few cases | 26.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 196 cases | No different | 13.6 per 1,000 likely 10.2 per 1,000 – 18.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 317 cases | No different | 12.6 per 100 likely 10 per 100 – 16 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 317 cases | No different | 5.6 per 100 likely 4.1 per 100 – 7.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 744 cases | No different | 0.9 likely 0.7 – 1.2 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
554 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 62 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Peer Specialist | 85 |
| Physician Assistant | 56 |
| Anesthesiology | 37 |
| Family | 32 |
| Internal Medicine | 26 |
| Diagnostic Radiology | 24 |
| Emergency Medicine | 23 |
| Nurse Anesthetist, Certified Registered | 23 |
| Acute Care | 22 |
| Nurse Practitioner | 17 |
| Anatomic Pathology & Clinical Pathology | 15 |
| Neonatal-Perinatal Medicine | 13 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.6M
- 2020 $1.6M
- 2021 $811,506
- 2022 $505,597
- 2023 $842,761
- 2024 $413,719
- 2025 $342,775
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $75,034 | 3 |
| Space rental and facility fees | $22,347 | 10 |
| Debt forgiveness | $7,549 | 10 |
| Charitable contributions | $5,000 | 1 |
| Medical devices and supplies on long-term loan | $3,372 | 5 |
| Education | $3,000 | 1 |
| Consulting fees | $2,500 | 1 |
| Food and beverage | $805 | 2 |
| Gifts | $500 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $80,696 | 4 |
| Gilead Sciences, Inc. | $77,284 | 3 |
| Genentech, Inc. | $69,507 | 7 |
| AstraZeneca UK Limited | $40,530 | 1 |
| CSL Behring | $24,134 | 7 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,000 | 2 |
| Pfizer INC. | $5,470 | 1 |
| Siemens Medical Solutions USA, Inc. | $5,350 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB IN ADULTS WITH PROGRESSIVE MS Genentech, Inc. | $66,549 |
| A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Compl… Novartis Pharmaceuticals Corporation | $53,494 |
| A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID… AstraZeneca UK Limited | $40,530 |
| Ribociclib Standard Endocrine therapy in patients with HR HER2 Early BC at High amp Intermediate Risk for Recurrence Novartis Pharmaceuticals Corporation | $27,202 |
| A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney… CSL Behring · NCT03744910 | $24,134 |
| RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF TUCATINIB OR PLACEBO IN COMBINATION WITH ADOTRASTUZUMAB EMTANSINE TDM1 FOR SUBJECTS WITH UNRESECTABLE LOCALLY… PFIZER INC. | $5,470 |
| Chemo trastuzumab vs chemo trastuzumab pertuzumab Genentech, Inc. | $2,958 |
| An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis E.R. Squibb & Sons, L.L.C. · NCT01357668 | $2,050 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Cooperman Barnabas Medical Center
Is Cooperman Barnabas Medical Center a good hospital?
Cooperman Barnabas Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 5. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Cooperman Barnabas Medical Center?
71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 2,189 completed HCAHPS surveys.
How long is the wait in the Cooperman Barnabas Medical Center emergency room?
Emergency patients spend a median of 2 h 9 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 0% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Cooperman Barnabas Medical Center receive money from drug and device companies?
Drug and device makers reported $342,775 in payments to Cooperman Barnabas Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.